Back to Search
Start Over
Dual NOX4/NOX1 inhibition by setanaxib halts cholangiocarcinoma progression by impairing cancer associated fibroblast activation.
- Source :
-
Free Radical Biology & Medicine . 2024 Supplement 1, Vol. 218, p45-45. 1p. - Publication Year :
- 2024
- Subjects :
- *CHOLANGIOCARCINOMA
*CANCER invasiveness
Subjects
Details
- Language :
- English
- ISSN :
- 08915849
- Volume :
- 218
- Database :
- Academic Search Index
- Journal :
- Free Radical Biology & Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 177629072
- Full Text :
- https://doi.org/10.1016/j.freeradbiomed.2024.04.160